What We're Reading: Page 327
Industry reads hand-picked by our editors
Aug 09, 2016
-
MIT Technology Review
Gene-Therapy Cure Has Money-Back Guarantee
-
BloombergGadfly
Allergan's buying something, if not Biogen
-
Reuters
Future of drug pricing: paying for benefits not per pill
-
Nature
Beyond CRISPR: A guide to the many other ways to edit a genome
Aug 08, 2016
-
Stat
How biotech executives profit from legal insider trades
-
Bloomberg
Why Big Pharma wants to switch billions of farm animals to vaccines from antibiotics
-
Washington Post
High prices make once-neglected ‘orphan’ drugs a booming business
-
Boston Globe
A lab is liquidated, and so is decade of cancer studies
Aug 05, 2016
-
The New England Journal of Medicine
Strengthening Research through Data Sharing
-
Wall Street Journal
Business Groups Sue U.S. Government Over Tax-Inversion Rules
-
Bloomberg
New York State to Require Hearing on Proposed Anthem-Cigna Deal
-
Reuters
Cephalon, U.S. states reach $125 million settlement over generic drugs
Previous
